Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CervoMed Inc. | SVP, Clinical Development | Common Stock | 13.7K | $248K | $18.16 | Aug 16, 2023 | Direct |
CervoMed Inc. | SVP, Clinical Development | Stock Option (Right to Buy) | 16K | Jan 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRVO | CervoMed Inc. | Jan 26, 2024 | 1 | $0 | 4 | Jan 26, 2024 | SVP, Clinical Development |
DFFN | CervoMed Inc. | Sep 15, 2023 | 1 | $0 | 4 | Sep 15, 2023 | VP, Clinical Development |
DFFN | CervoMed Inc. | Aug 16, 2023 | 0 | $0 | 3 | Aug 23, 2023 | VP, Clinical Development |